Counselors in Mount Arlington, NJ Accepting Medicare

5 Counselors found. Showing 1 - 5

Paul Depinto, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 22 Howard Blvd, Suite 101, Mount Arlington, NJ 07856 Phone: 973-770-7600    Fax: 973-770-7601

Ronald Redmerski, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 22 Howard Blvd Ste 101, Mount Arlington, NJ 07856 Phone: 973-770-7600

Sophia Kerkoulas Counselor Medicare: Not Enrolled in Medicare Practice Location: 9202 Fieldstone Dr, Mount Arlington, NJ 07856 Phone: 973-876-8993

Jocelyn Blais Drukker, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 90 Brookside Ln, Mount Arlington, NJ 07856 Phone: 201-230-1654

Kimberly Grace Mccloskey Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 52 Edgemere Ave, Mount Arlington, NJ 07856 Phone: 973-768-4748

News Archive

Cyberonics to develop medical devices with cutting edge technology for persons suffering from epilepsy

Cyberonics, Inc. today announced another in a series of collaborations around seizure detection technology aimed at advancing its development of new and more efficacious medical devices for persons suffering from epilepsy.

Invertebrate immune systems are anything but simple

A hundred years since Russian microbiologist Elie Metschnikow first discovered the invertebrate immune system, scientists are only just beginning to understand its complexity.

BioCryst reports results from forodesine studies for CTCL and CLL

BioCryst Pharmaceuticals, Inc. announced preliminary top-line results from its multinational, open-label, single-arm trial evaluating 200 mg once-daily oral forodesine in the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL), as well as interim results from the Company's exploratory Phase 2 study to investigate the efficacy and safety of 200 mg twice-daily oral forodesine as monotherapy for chronic lymphocytic leukemia (CLL).

Preterm birth: Pre-pregnancy obesity and gestational weight gain increase risk

Researchers at Boston University School of Medicine's (BUSM) Slone Epidemiology Center and Boston University School of Public Health (BUSPH) have found that pre-pregnancy obesity and gestational weight gain are associated with an increased risk of preterm birth in African American participants from the Black Women's Health Study. This study currently appears on-line in Epidemiology.

BD receives CEO Cancer Gold Standard accreditation

BD has received CEO Cancer Gold Standard accreditation, recognizing the company's commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for its own employees and their covered family members.

Read more Medical News

› Verified 8 days ago